Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy

Cancer is identified as one of the main causes of death worldwide, and an effective treatment that can reduce/eliminate serious adverse effects is still an unmet medical need. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), has demonstrated promising antitumoral properties. However, the...

Descripció completa

Dades bibliogràfiques

Autors principals:	Gerard Esteruelas, Eliana B. Souto, Marta Espina, María Luisa García, Marta Świtalska, Joanna Wietrzyk, Anna Gliszczyńska, Elena Sánchez-López
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2022-12-01
Col·lecció:	Pharmaceutics
Matèries:	diclofenac nanoparticles PLGA anti-inflammatory drug delivery anti-angiogenesis
Accés en línia:	https://www.mdpi.com/1999-4923/15/1/102
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!